These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [ Kanellopoulos P; Kaloudi A; Rouchota M; Loudos G; de Jong M; Krenning EP; Nock BA; Maina T Pharmaceutics; 2020 Nov; 12(12):. PubMed ID: 33256013 [TBL] [Abstract][Full Text] [Related]
9. Radiometal-Dependent Biological Profile of the Radiolabeled Gastrin-Releasing Peptide Receptor Antagonist SB3 in Cancer Theranostics: Metabolic and Biodistribution Patterns Defined by Neprilysin. Lymperis E; Kaloudi A; Sallegger W; Bakker IL; Krenning EP; de Jong M; Maina T; Nock BA Bioconjug Chem; 2018 May; 29(5):1774-1784. PubMed ID: 29664606 [TBL] [Abstract][Full Text] [Related]
10. 99mTc radiotracers based on human GRP(18-27): synthesis and comparative evaluation. Marsouvanidis PJ; Maina T; Sallegger W; Krenning EP; de Jong M; Nock BA J Nucl Med; 2013 Oct; 54(10):1797-803. PubMed ID: 24009275 [TBL] [Abstract][Full Text] [Related]
11. Amide-to-triazole switch vs. in vivo NEP-inhibition approaches to promote radiopeptide targeting of GRPR-positive tumors. Maina T; Kaloudi A; Valverde IE; Mindt TL; Nock BA Nucl Med Biol; 2017 Sep; 52():57-62. PubMed ID: 28636973 [TBL] [Abstract][Full Text] [Related]
12. Preclinical and first clinical experience with the gastrin-releasing peptide receptor-antagonist [⁶⁸Ga]SB3 and PET/CT. Maina T; Bergsma H; Kulkarni HR; Mueller D; Charalambidis D; Krenning EP; Nock BA; de Jong M; Baum RP Eur J Nucl Med Mol Imaging; 2016 May; 43(5):964-973. PubMed ID: 26631238 [TBL] [Abstract][Full Text] [Related]
13. New Gastrin Releasing Peptide Receptor-Directed [ Nock BA; Charalambidis D; Sallegger W; Waser B; Mansi R; Nicolas GP; Ketani E; Nikolopoulou A; Fani M; Reubi JC; Maina T J Med Chem; 2018 Apr; 61(7):3138-3150. PubMed ID: 29517903 [TBL] [Abstract][Full Text] [Related]
14. Trastuzumab cotreatment improves survival of mice with PC-3 prostate cancer xenografts treated with the GRPR antagonist Mitran B; Rinne SS; Konijnenberg MW; Maina T; Nock BA; Altai M; Vorobyeva A; Larhed M; Tolmachev V; de Jong M; Rosenström U; Orlova A Int J Cancer; 2019 Dec; 145(12):3347-3358. PubMed ID: 31077356 [TBL] [Abstract][Full Text] [Related]